The optimal dose of esomeprazole for anti-Helicobacter pylori therapy

被引：1

作者：

Hsu, PI ^{[1
]}

Lai, KH

Lo, GH

机构：

[1] Kaohsiung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan

[2] Natl Yang Ming Univ, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 06期

关键词：

D O I：

10.1111/j.1572-0241.2006.00595_6.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1399 / 1400

页数：2

共 6 条

[1] Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection [J].

Anagnostopoulos, GK ;

Tsiakos, S ;

Margantinis, G ;

Kostopoulos, P ;

Arvanitidis, D .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (06) :503-506

[2] A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication [J].

Hsu, PI ;

Lai, KH ;

Lin, CK ;

Chen, WC ;

Yu, HC ;

Cheng, JS ;

Tsay, FW ;

Wu, CJ ;

Lo, CC ;

Tseng, HH ;

Yamaoka, Y ;

Chen, JL ;

Lo, GH .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11) :2387-2392

[3] Review article:: esomeprazole in the treatment of Helicobacter pylori [J].

Laine, L .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 :115-118

[4]

Laine L, 2000, AM J GASTROENTEROL, V95, P3393, DOI 10.1111/j.1572-0241.2000.03349.x

[5] Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism [J].

Sheu, BS ;

Kao, AW ;

Cheng, HC ;

Hunag, SF ;

Chen, TW ;

Lu, CC ;

Wu, JJ .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (03) :283-288

[6]

Van Zanten SV, 2000, ALIMENT PHARM THER, V14, P1605

← 1 →